Bio-Rad Laboratories, Inc.
BIO
株式のランク
#2157
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
株価
$354.75
最終同期: 2026-10-20
時価総額
$9.49B
変化（1日）
0.76%
変化（1年）
7.09%
国
US
取引 Bio-Rad Laboratories, Inc. (BIO)
カテゴリー
Healthcare
Bio-Rad Laboratories, Inc.（BIO）の収益
Jun 2026 時点の収益 TTM: $2.59B
Bio-Rad Laboratories, Inc. の最新の財務報告によると、現在の収益 (TTM) は $2.59B です。2024 年には $2.57B の収益があり、これは 2023 年の $2.67B と比較して 減少 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Bio-Rad Laboratories, Inc. の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $2.59B | 0.24% |
| 2025 | $2.58B | 0.65% |
| 2024 | $2.57B | -3.92% |
| 2023 | $2.67B | -4.67% |
| 2022 | $2.80B | -4.12% |
| 2021 | $2.92B | 14.81% |
| 2020 | $2.55B | 10.12% |
| 2019 | $2.31B | 0.94% |
| 2018 | $2.29B | 6.02% |
| 2017 | $2.16B | 4.45% |
| 2016 | $2.07B | 2.41% |
| 2015 | $2.02B | -7.15% |
| 2014 | $2.18B | 1.99% |
| 2013 | $2.13B | 3.07% |
| 2012 | $2.07B | -0.21% |
| 2011 | $2.07B | 7.60% |
| 2010 | $1.93B | 8.01% |
| 2009 | $1.78B | 1.13% |
| 2008 | $1.76B | 20.76% |
| 2007 | $1.46B | 14.69% |
| 2006 | $1.27B | 7.87% |
| 2005 | $1.18B | 8.35% |
| 2004 | $1.09B | 8.63% |
| 2003 | $1.00B | 12.40% |
| 2002 | $892.72M | 9.20% |
| 2001 | $817.51M | 12.62% |
| 2000 | $725.88M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.59B | 1,699.13% |
US
|
|
| $35.48B | 1,270.41% |
IE
|
|
| $25.84B | 897.84% |
US
|
|
| $21.00B | 710.88% |
US
|
|
| - | - |
DE
|
